SEC Form 4 · accession 0001179110-17-004436
AbbVie Inc. · ABBV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard A Gonzalez
Officer — Chairman of the Board and CEO · Director
Period of report
Mar 8, 2017
Accepted (ET)
Mar 10, 2017 · 5:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551152
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.01 par value | Mar 8, 2017 | M | 18,366 | $24.2082 | A | 369,113 | D | |
| Common stock, $0.01 par value | Mar 8, 2017 | M | 53,650 | $29.2265 | A | 422,763 | D | |
| Common stock, $0.01 par value | Mar 8, 2017 | S | 72,016 | $64.25 | D | 350,747 | D | |
| Common stock, $0.01 par value | Mar 10, 2017 | G | 785 | $0.00 | D | 349,962 | D | |
| Common stock, $0.01 par valueF1 | holding | — | — | — | 4,600 | I | By spouse | |
| Common stock, $0.01 par valueF1 | holding | — | — | — | 450 | I | By step-daughter |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F2 | $24.2082 | Mar 8, 2017 | M | 18,366 | D | Feb 18, 2013 | Feb 17, 2021 | Common stock | 18,366 | 0 | D |
| Option (right to buy)F2 | $29.2265 | Mar 8, 2017 | M | 53,650 | D | Feb 17, 2015 | Feb 22, 2022 | Common stock | 53,650 | 0 | D |
Explanation of responses
- F1The reporting person disclaims beneficial ownership of these securities.
- F2Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
Remarks
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).